Journal News

It's time to complete your
JBC Methods Madness bracket

Make your predictions for a chance to win a $50 Amazon gift card
ASBMB Today Staff
Feb. 24, 2020

Calling all scientists! Do you have a favorite method? Is there a biochemical technique you think has had monumental impacts on basic research and deserves a moment in the spotlight? The Journal of Biological Chemistry’s Methods Madness tournament is the chance you’ve been waiting for to voice your opinions. The person with the top-scoring bracket will win a $50 gift card.  

How to participate

  1. Download and fill in your bracket. Use the editable PDF to make your predictions. Save your changes! 
  2. Email your bracket to JBC. Double-check your entry, and then email it to methods@asbmb.org.
  3. Follow JBC on Twitter and vote for your favorite methods. The JBC Twitter handle is @JBiolChem. They'll be posting weekly polls. Don't forget to participate.

Visit the JBC Methods Madness website for the complete rules.

A note about JBC methods

It's well known that science progresses by building on the shoulders of those who came before. That's especially true for papers that report new tools — genetic constructs, small molecules, model organisms, etc. — that can be directly used by colleagues to jump-start a new project or resolve a technical hurdle. And at JBC, our high standards for rigor and reproducibility mean that readers can trust published tools to work as promised.  

— Lila Gierasch, JBC editor-in-chief

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.

How copper delivery fuels bacterial respiration
Journal News

How copper delivery fuels bacterial respiration

April 1, 2026

Researchers identify the roles of several proteins in copper homeostasis in the aerobic bacterium Caulobacter vibrioides.

Revealing the glycoproteome of a cancer subtype
Journal News

Revealing the glycoproteome of a cancer subtype

March 31, 2026

Researchers mapped the glycoproteome of extrahepatic cholangiocarcinoma and compared it to intrahepatic tumors. Differences in sugar modifications and immune cell content suggest new biomarkers and guide development of targeted immunotherapies.

Uncovering the mechanisms of a glycosylation disorder
Journal News

Uncovering the mechanisms of a glycosylation disorder

March 27, 2026

Mutations in OGT, an enzyme that adds sugars to proteins, cause a rare neurological disorder. Using proteomics, researchers reveal how OGT interactions with TET proteins may trigger epigenetic changes and early neural defects.

Heat shock proteins as a promising breast cancer therapeutic
Journal News

Heat shock proteins as a promising breast cancer therapeutic

March 25, 2026

Researchers unveiled isoform-specific targets on heat shock protein 90 which may be beneficial in therapeutic development.